BridgeBio Pharma, Inc.

BBIO · Nasdaq · SIC 2834: Pharmaceutical Preparations
138
SEC Filings

Business Summary

PART I Overview A New Type of Biopharmaceutical Company BridgeBio Pharma, Inc. is a commercial-stage, multi-product biopharmaceutical company organized around a portfolio operating model to discover, develop, and deliver medicines for patients with genetic diseases. We seek to translate advances in genetic science into therapies for patient populations with significant unmet medical needs. Since our founding 10 years ago, we have advanced multiple programs from discovery through regulatory appro...

Next Earnings

Q2 FY2026 — expected 2026-08-09

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionBBIOdiscussed_in_filing Cybersecurity
topic_mentionBBIOdiscussed_in_filing Trusted Computing
topic_mentionBBIOdiscussed_in_filing Blockchain & Crypto
topic_mentionBBIOdiscussed_in_filing Regulation
topic_mentionBBIOdiscussed_in_filing Healthcare & Bio
topic_mentionBBIOdiscussed_in_filing Cybersecurity
topic_mentionBBIOdiscussed_in_filing Trusted Computing
topic_mentionBBIOdiscussed_in_filing Blockchain & Crypto
topic_mentionBBIOdiscussed_in_filing Regulation
topic_mentionBBIOdiscussed_in_filing Healthcare & Bio
topic_mentionBBIOdiscussed_in_filing Cybersecurity
topic_mentionBBIOdiscussed_in_filing Trusted Computing
topic_mentionBBIOdiscussed_in_filing Blockchain & Crypto
topic_mentionBBIOdiscussed_in_filing Regulation
topic_mentionBBIOdiscussed_in_filing Healthcare & Bio
topic_mentionBBIOdiscussed_in_filing Cybersecurity
topic_mentionBBIOdiscussed_in_filing Trusted Computing
topic_mentionBBIOdiscussed_in_filing Blockchain & Crypto
topic_mentionBBIOdiscussed_in_filing Regulation
topic_mentionBBIOdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-242025-12-310001743881-26-000009EDGAR152K words
2025-02-202024-12-310000950170-25-024119EDGAR
2024-02-222023-12-310000950170-24-018811EDGAR
2023-02-232022-12-310000950170-23-004145EDGAR
2022-02-252021-12-310000950170-22-002030EDGAR
2021-02-252020-12-310001564590-21-008969EDGAR
2020-03-032019-12-310001564590-20-008260EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-10-292025-09-300001743881-25-000012EDGAR50K words
2025-08-052025-06-300000950170-25-103192EDGAR
2025-04-292025-03-310000950170-25-060314EDGAR
2024-11-122024-09-300000950170-24-124577EDGAR
2024-08-012024-06-300000950170-24-089326EDGAR
2024-05-022024-03-310000950170-24-052165EDGAR
2023-11-022023-09-300000950170-23-058255EDGAR
2023-08-032023-06-300000950170-23-037977EDGAR
2023-05-042023-03-310000950170-23-017812EDGAR
2022-11-032022-09-300000950170-22-021936EDGAR
2022-08-042022-06-300000950170-22-014824EDGAR
2022-05-052022-03-310000950170-22-007874EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-300001140361-26-011991EDGAR1K words
2026-02-240001743881-26-000008EDGAR
2026-02-120001140361-26-004995EDGAR
2026-01-210001140361-26-001843EDGAR
2026-01-120001140361-26-000971EDGAR
2025-10-290001140361-25-039705EDGAR
2025-10-290001743881-25-000010EDGAR
2025-10-270001140361-25-039463EDGAR
2025-08-050000950170-25-102985EDGAR
2025-07-020001140361-25-024413EDGAR

138 total filings indexed. 109 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001743881
TickerBBIO
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 9d6884fe554966c43979f3043c81760b6adab4441eeeac87c6da71b5d2e46a25
parent: a62026001f5eabe933cdc2f8d906b3b57eaf1ccf154d42cf78b3812f8a1643d8
content hash: 69b800609f5db59bf6cfbe16c87d1b658c7f89a0692ef22cf3bd5b1e9c4e1acb
signed: 2026-04-13T04:43:53.085Z
sources: 19 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf